Blog
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better
URBN vs. IDEXY: Which Stock Should Value Investors Buy Now?
Investors interested in Retail - Apparel and Shoes stocks are likely familiar with Urban Outfitters (URBN) and Industria de Diseno Textil SA (IDEXY). But which of these two companies is the best
AXS or KNSL: Which Is the Better Value Stock Right Now?
Investors with an interest in Insurance - Property and Casualty stocks have likely encountered both Axis Capital (AXS) and Kinsale Capital Group, Inc. (KNSL). But which of these two companies is the
TPH or SDHC: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Building Products - Home Builders sector might want to consider either Tri Pointe Homes (TPH) or Smith Douglas Homes Corp. (SDHC). But which of these two
FLEX or ROK: Which Is the Better Value Stock Right Now?
Investors with an interest in Electronics - Miscellaneous Products stocks have likely encountered both Flex (FLEX) and Rockwell Automation (ROK). But which of these two companies is the best option
Weak Macro Can't Stop E-commerce Stocks Expedia and Amazon
Schwab Hits 52-Week High: Is This the Right Time to Buy SCHW for 2026?
Charles Schwab SCHW touched a 52-week high of $102.05 during yesterday’s trading session as solid GDP numbers indicate a resilient economy and future earnings growth. Over the past three months
Zoom (ZM) Up 1% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Zoom Communications (ZM). Shares have added about 1% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue
Semtech (SMTC) Up 5.8% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Semtech (SMTC). Shares have added about 5.8% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the
Keysight (KEYS) Up 5% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Keysight (KEYS). Shares have added about 5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent
Woodward (WWD) Up 7.7% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Woodward (WWD). Shares have added about 7.7% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the
Why Is Agilent (A) Down 12% Since Last Earnings Report?
It has been about a month since the last earnings report for Agilent Technologies (A). Shares have lost about 12% in that time frame, underperforming the S&P 500.
Will the recent negative trend
Why Is Central Garden (CENT) Down 5.6% Since Last Earnings Report?
It has been about a month since the last earnings report for Central Garden (CENT). Shares have lost about 5.6% in that time frame, underperforming the S&P 500.
But investors have to be wondering
Invest in Tomorrow's Space Economy With These ETFs
Driven by rapid innovation and growing investor interest, the space economy is gaining momentum. The S&P Kensho Space Index’s outperformance compared with the S&P 500 highlights rising confidence
Can ERNIE 5.0 and Qianfan Strengthen Baidu's AI Cloud Advantage?
Baidu’s BIDU AI Cloud business is gaining strategic significance as the company sharpens its focus on scaling its foundation model ecosystem and deepening enterprise use cases. The introduction of
FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug
Sanofi SNY announced that the FDA has issued a complete response letter (CRL) to its new drug application (NDA), seeking approval for its investigational Bruton's tyrosine kinase (BTK) inhibitor
PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth
Pfizer PFE expects a significant negative impact on revenues from the loss of exclusivity (“LOE”) of several of its key products in the 2026-2030 period. These include Eliquis, Vyndaqel, Ibrance
Vistra Stock Slips Below 50-Day SMA: What Should Investors Do Now?
Vistra Corp. VST has been trading below its 50-day simple moving average (SMA), signaling a short-term bearish trend. The stock closed at $161.67 as of Dec. 23, 2025, down 26.5% from its 52-week
Nu Holdings' Rapid Customer Gains Are Reshaping Fintech Growth
Nu Holdings Ltd. NU continues to gain momentum, adding 4.3 million customers in the third quarter of 2025 alone. That pushed its total to 127 million, marking a 16% year-over-year rise and
3 Industrial REITs Well-Positioned to Deliver Strong Growth in 2026
The U.S. industrial real estate market remains resilient despite tariffs and business volatility. Growth in e-commerce continues to support demand, with robust leasing at high-quality, tech-enabled
Intel Rides on Strong Gross Margin Expansion: Will it Sustain?
Intel Corporation INTC reported a non-GAAP gross profit of $5.45 billion during the third quarter of 2025, up from $2.39 billion a year ago. Non-GAAP operating margin improves to 40% from 18% a year
Soft Weekly Jobless Claims Data
Pre-market futures are lower than yesterday’s close, which saw major indexes rise between +0.2% (Dow) and +0.6% (Nasdaq) on seasonal low volume (Xmas week), but hovering right around breakeven at
Reasons Why You Should Retain ABM Industries Stock in Your Portfolio
ABM Industries ABM has a Growth Score of B, which condenses key financial metrics to reflect a fair sense of the quality and sustainability of its growth.
ABM’s fiscal 2026 and 2027 earnings are
Americold Partners With OTR to Deliver Storage & Distribution Services
Americold Realty Trust COLD recently joined forces with On the Run (OTR), one of Australia’s most recognized P&C brands, to deliver storage and distribution solutions supporting OTR’s supply chain



